ENTITY

Trevena (TRVN US)

Health CareUnited States
Trevena, Inc. develops pharmaceutical products. The Company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, acute chronic pain, and depression. Trevena serves customers throughout the United States.
more
Refresh
22 Mar 2024 04:23

Current Report (Form 8-K | Period ending 2024-03-21)

Exchange Announcement
Share
07 Mar 2024 06:00

Current Report (Form 8-K | Period ending 2024-03-01)

Exchange Announcement
Share
01 Feb 2024 20:05

Current Report (Form 8-K | Period ending 2024-01-30)

Exchange Announcement
Share
24 Jan 2024 05:15

US SEC Form 424B3 for Trevena Inc

Exchange Announcement
Share
20 Jan 2024 05:30

US SEC Form S-3/A for Trevena Inc

Exchange Announcement
Share
x